Cargando…

Thromboses and COVID-19: reducing inflammation in addition to thromboprophylaxis

Detalles Bibliográficos
Autores principales:	Mehta, Puja, Haskard, Dorian O, Laffan, Michael A, Chambers, Rachel C, Hunt, Beverley J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832098/ https://www.ncbi.nlm.nih.gov/pubmed/33521654 http://dx.doi.org/10.1016/S2665-9913(21)00003-5

Ejemplares similares

Thromboprophylaxis Strategies for Hospitalized Patients With COVID-19
por: Porres-Aguilar, Mateo, et al.
Publicado: (2022)

Thromboprophylaxis in COVID-19: Anti-FXa—the Missing Factor?
por: Dutt, Tina, et al.
Publicado: (2020)

Anti-FXa Activity with Intermediate-Dose Thromboprophylaxis in COVID-19
por: Rappaport, Stephen H., et al.
Publicado: (2020)

B-cell depletion with rituximab in the COVID-19 pandemic: where do we stand?
por: Mehta, Puja, et al.
Publicado: (2020)

Reducing the burden of venous thromboembolism in the acute medically ill population with extended-duration thromboprophylaxis
por: Ageno, Walter, et al.
Publicado: (2018)

Reply to Rappaport et al.: Anti-FXa Activity with Intermediate-Dose Thromboprophylaxis in COVID-19
por: Dutt, Tina, et al.
Publicado: (2020)

Thromboprophylaxis for venous thromboembolism prevention in hip fracture patients
Publicado: (2017)

Management of perioperative thromboprophylaxis for surgery following COVID-19: an expert-panel survey
por: Ferrandis, Raquel, et al.
Publicado: (2021)

Thrombose und COVID-19
por: Tzaneva, Stanislava
Publicado: (2021)

Chilblain-like acral lesions in long COVID-19: management and implications for understanding microangiopathy
por: Mehta, Puja, et al.
Publicado: (2021)

Neurogenic Inflammation: Additional Points
por: Shusterman, Dennis
Publicado: (1994)

Renal function in the ICU: always look both ways before initiating venous thromboprophylaxis
por: Baptista, João Pedro, et al.
Publicado: (2023)

Fish oil and COVID-19 thromboses
por: Merritt, Russell J., et al.
Publicado: (2020)

COVID-19 : coagulopathie et thrombose
por: Tazi Mezalek, Z.
Publicado: (2021)

Thromboprophylaxis in lower limb immobilisation after injury (TiLLI)
por: Horner, Daniel, et al.
Publicado: (2020)

The challenge of pharmacological thromboprophylaxis in ICU patients: anti-FXa activity does not constitute the simple solution. Author's reply
por: Hofmaenner, Daniel A., et al.
Publicado: (2022)

Thromboses veineuses après vaccination COVID-19
por: Monsuez, J.-J.
Publicado: (2022)

Stroke and Thromboprophylaxis in the Era of COVID-19
por: Ma, Alice, et al.
Publicado: (2021)

Coagulation abnormalities & thromboprophylaxis in COVID-19
por: Jandial, Aditya, et al.
Publicado: (2021)

Thromboprophylaxis in COVID-19 – Rationale and considerations
por: Bristogiannis, Sotirios, et al.
Publicado: (2021)

Extended Thromboprophylaxis in Patients with COVID-19
por: Zhao, Wei, et al.
Publicado: (2021)

Thromboprophylaxis strategies for COVID-19 patients
por: Porres-Aguilar, Mateo, et al.
Publicado: (2022)

Thromboprophylaxis in Patients With Cancer and COVID-19
por: Lecumberri, Ramón, et al.
Publicado: (2022)

Is thromboprophylaxis effective in reducing the pulmonary thromboembolism?
por: Rajabi, Fereshteh, et al.
Publicado: (2012)

Quantifying additional COVID-19 symptoms will save lives
por: Menni, Cristina, et al.
Publicado: (2020)

Risk of arterial and venous thromboses after COVID-19
por: Whiteley, William, et al.
Publicado: (2022)

Pharmacologic therapeutic options for thromboprophylaxis in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Thromboprophylaxis strategies to improve the prognosis of COVID-19
por: Bertoletti, Laurent, et al.
Publicado: (2021)

Additional considerations for assessing COVID-19 impact on dengue transmission
por: Yek, Christina, et al.
Publicado: (2022)

Granulocyte-macrophage colony stimulating factor in COVID-19: friend or foe?
por: Mehta, Puja, et al.
Publicado: (2021)

Does inflammation help during COVID-19?
por: Sharma, Lokesh, et al.
Publicado: (2020)

Evolution of the Macrophage CD163 Phenotype and Cytokine Profiles in a Human Model of Resolving Inflammation
por: Evans, Betsy J., et al.
Publicado: (2013)

Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review
por: Parker, Edward P K, et al.
Publicado: (2022)

Thromboses artérielles au cours de la COVID-19
por: Emmerich, J.
Publicado: (2021)

Medikamentöse Thrombose-Prophylaxe bei ambulanten COVID-19-Patienten
por: Darius, Harald, et al.
Publicado: (2021)

Wastewater surveillance: an effective and adaptable surveillance tool in settings with a low prevalence of COVID-19
por: Paterson, Beverley J, et al.
Publicado: (2022)

Additional considerations for assessing COVID-19 impact on dengue transmission – Authors' reply
por: Brady, Oliver J, et al.
Publicado: (2022)

Kidney Transplant Recipients With COVID-19 and Monoclonal Antibody Therapy: Additional Considerations
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Preeclampsia and COVID-19 in Afghanistan: additional burden on Afghan pregnant women’s health
por: Mohammady, Nooria, et al.
Publicado: (2023)

Hospital-based use of thromboprophylaxis in patients with COVID-19
por: Spyropoulos, Alex C, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f7n5v5u0iaj21rg1rqduoom9f6